Sun-Chuan Dai * UCSF Profiles

Sun-Chuan Dai, MD

Title(s)	Assistant Professor, Medicine
School	School of Medicine
Phone	415-206-7473
vCard	Download vCard

Biography

Education and Training

University of Pennsylvania	Advanced Endoscopy	2014
Boston University Medical Center	Gastroenterology	2013
Cedars-Sinai Medical Center	Internal Medicine	2009
Baylor College of Medicine	MD	2006

Overview

Interests

Endoscopic ultrasound, endoscopic retrograde cholangiopancreatography (ERCP), pancreatic cysts (diagnosis and management), intragastric weight-loss balloons, staging of gastrointestinal cancers, benign and malignant biliary stricture management, stone disease, other pancreaticobiliary disorders including ampullary adenoma resection, cholangiocarcinoma, autoimmune pancreatitis, pancreatic cancer, neuroendocrine tumors of the gastrointestinal tract.

ORNG Applications

Featured Publications

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.

List All | Timeline

Dai SC, Goldberg D, Agarwal A, Ma GK, Yam C, Ahmad NA, Ginsberg GG, Jaffe DL, Kochman ML, Olthoff KM, Chandrasekhara V. Endoscopic Therapy is Effective for Recurrent Anastomotic Biliary Strictures after Orthotopic Liver Transplantation. Ann Hepatol. 2017 November-December,; 16(6):924-931. PMID: 29055929.

View in: PubMed
Cuevas-Ocampo AK, Bollen AW, Goode B, Pajtler KW, Chavez L, Sharma T, Dai SC, McDermott M, Perry A, Korshunov A, Solomon DA. Genetic confirmation that ependymoma can arise as part of multiple endocrine neoplasia type 1 (MEN1) syndrome. Acta Neuropathol. 2017 04; 133(4):661-663. PMID: 28238068.

View in: PubMed
Dai SC, Paley M, Chandrasekhara V. Intragastric balloons: an introduction and removal technique for the endoscopist. Gastrointest Endosc. 2015 Dec; 82(6):1122. PMID: 26183825.

View in: PubMed
Pimentel M, Morales W, Lezcano S, Sun-Chuan D, Low K, Yang J. Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth. Gastroenterol Hepatol (N Y). 2009 Jun; 5(6):435-42. PMID: 20574504; PMCID: PMC2886395.

View in: PubMed, PubMed Central
Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci. 2008 Jun; 53(6):1443-54. PMID: 17990113.

View in: PubMed